Agilon Health Inc (AGL) Institutional Buying & Selling Tracker (Q2 2026)

AGL ranks #3255 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

AGL is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

AGL is a top-conviction position for Clayton, Dubilier & Rice, LLC — at 47.9% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Cliff Asness has added to its AGL position for two straight quarters, increasing it by $67.2M to reach $74.2M today.

Quantbot Technologies LP has trimmed its AGL position for two straight quarters, cutting it by $28.0K while still holding $25.9K.

AGL is down 0.1% today, but institutions show net buying of $1.7B this quarter — a divergence between today's price move and the underlying institutional flow.

AGL reported a net loss of $232.2M over the trailing twelve months.

• Not yet profitable — net loss of $232.2M over the trailing twelve months
• Revenue grew 0.3% year over year
• Net income improved year over year, from -$315.7M to -$232.2M
• Operating cash flow was negative, using $105.8M in cash
• Current ratio of 1.02x — below the conventional 1.5x liquidity buffer
• Liabilities run 9.03x equity — a highly leveraged balance sheet worth noting